Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 20, Issue 4, Pages R183-R201
Publisher
Bioscientifica
Online
2013-04-27
DOI
10.1530/erc-13-0099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial
- (2013) F. Boccardo et al. EUROPEAN JOURNAL OF CANCER
- mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions
- (2012) C. Villarreal-Garza et al. ANNALS OF ONCOLOGY
- Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer
- (2012) M. T. Weigel et al. ANNALS OF ONCOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
- (2012) John F. R. Robertson et al. BREAST CANCER RESEARCH AND TREATMENT
- Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels
- (2012) Caroline Diorio et al. BREAST CANCER RESEARCH AND TREATMENT
- Abstract 81: Role of GRM1 in breast cancer
- (2012) Madhura S. Mehta et al. CANCER RESEARCH
- Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast Cancer
- (2012) Shaheenah Dawood et al. Clinical Breast Cancer
- Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going?
- (2012) Palma Fedele et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
- (2012) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
- (2012) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group
- (2012) Peter C. Dubsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- (2012) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
- (2012) J Sven D Mieog et al. LANCET ONCOLOGY
- Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator
- (2012) Shannon Wills et al. Journal of Oncology Practice
- Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project
- (2011) Marilyn L. Kwan et al. BREAST CANCER RESEARCH AND TREATMENT
- Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation
- (2011) P. E. Lonning et al. CLINICAL CANCER RESEARCH
- Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study
- (2011) Marco Colleoni et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
- (2011) Todd W. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
- (2011) Georg Pfeiler et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study
- (2011) Judith M. Bliss et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
- (2011) B Weigelt et al. ONCOGENE
- PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
- (2011) V Serra et al. ONCOGENE
- Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
- (2011) J. Baselga ONCOLOGIST
- Significance of ER–Src axis in hormonal therapy resistance
- (2010) Sreeram Vallabhaneni et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Intratumoral Estrogen Disposition in Breast Cancer
- (2010) B. P. Haynes et al. CLINICAL CANCER RESEARCH
- Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
- (2010) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
- (2010) James N. Ingle et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance
- (2010) Gauri Sabnis et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
- (2009) M Hauglid Flågeng et al. BRITISH JOURNAL OF CANCER
- Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer
- (2009) Matthew J. Ellis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aromatase Inhibitor–Induced Carpal Tunnel Syndrome: Results From the ATAC Trial
- (2009) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor–Related Arthralgia
- (2009) Omer Dizdar et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
- (2009) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
- (2009) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole
- (2009) William R. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status
- (2009) P.E. Lønning et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Aromatase deficiency in men: a clinical perspective
- (2009) Vincenzo Rochira et al. Nature Reviews Endocrinology
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
- (2008) M. Untch et al. ANNALS OF ONCOLOGY
- Increase in response rate by prolonged treatment with neoadjuvant letrozole
- (2008) J. Michael Dixon et al. BREAST CANCER RESEARCH AND TREATMENT
- Carpal Tunnel Syndrome Associated with the Use of Aromatase Inhibitors in Breast Cancer
- (2008) Taiga Nishihori et al. Clinical Breast Cancer
- Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels
- (2008) J. Geisler et al. CLINICAL CANCER RESEARCH
- Indications and limitations of third-generation aromatase inhibitors
- (2008) Per Eystein Lønning et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer
- (2008) J. Michael Dixon et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome
- (2008) Leilani Morales et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
- (2008) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT
- (2008) Stephen Chia et al. JOURNAL OF CLINICAL ONCOLOGY
- Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial
- (2008) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples
- (2008) Jürgen Geisler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways
- (2008) Emily M. Fox et al. STEROIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search